Baker Bros. Advisors LP Pacific Biosciences Of California, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $17 Million - $37 Million	-4,317,181 Reduced 79.29%	1,127,782 $6.55 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $55.8 Million - $78.5 Million	2,242,991 Added 70.05%	5,444,963 $139 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $504,294 - $1.37 Million	-48,028 Reduced 1.48%	3,201,972 $83.1 Million
Q3 2020 Nov 16, 2020	BUY	$3.61 - $9.87 $11.7 Million - $32.1 Million	3,250,000 New	3,250,000 $32.1 Million

255

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $450M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.